Published in J Biol Chem on November 10, 1966
Bacteriophages of Bacillus subtilis. Bacteriol Rev (1975) 2.77
Biological activity of 5-hydroxymethyluracil and its deoxynucleoside in noninfected and phage-infected Bacillus subtilis. J Virol (1969) 0.90
Purification and some properties of an IMP-specific 5'-nucleotidase from yeast. Biochem J (1994) 0.85
Sequential cleavage of dinucleotides from DNA by phage Sp3 DNAse. Proc Natl Acad Sci U S A (1968) 0.79
Isolation of a cell membrane-DNA-nascent RNA complex from bacteria. J Mol Biol (1969) 4.94
Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect (1999) 3.07
DNA replication studied by a new method for the isolation of cell membrane-DNA complexes. Cold Spring Harb Symp Quant Biol (1968) 2.38
DNA-DNA hybridization on filters at low temperature in the presence of formamide or urea. Biochimie (1971) 1.80
DMSA and DMPS--water soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol (1983) 1.76
Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol (2001) 1.72
Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol (2001) 1.65
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. J Pediatr (1994) 1.58
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58
Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB J (1991) 1.27
Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem Res Toxicol (1995) 1.26
Rabbit muscle creatine phosphokinase. CDNA cloning, primary structure and detection of human homologues. J Biol Chem (1984) 1.24
The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci (1999) 1.16
Neurobehavioral effects from exposure to dental amalgam Hg(o): new distinctions between recent exposure and Hg body burden. FASEB J (1998) 1.10
N-(2,3-dimercaptopropyl)phthalamidic acid (DMPA) increases polonium-210 excretion. Biol Met (1990) 1.07
Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem Res Toxicol (1999) 1.04
A deoxyribonuclease found after infection of Bacillus subtilis with phage SP3. Proc Natl Acad Sci U S A (1965) 1.04
DNA and gene therapy: uncoating of polyoma pseudovirus in mouse embryo cells. Proc Natl Acad Sci U S A (1970) 1.04
Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic. Toxicol Appl Pharmacol (1996) 1.02
DNA and gene therapy: transfer of mouse DNA to human and mouse embryonic cells by polyoma pseudovirions. Proc Natl Acad Sci U S A (1971) 1.02
Formation of nucleoprotein complexes between polyoma empty capsides and DNA. J Virol (1975) 1.01
Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. J Pharmacol Exp Ther (1994) 0.98
Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. J Pharmacol Exp Ther (1991) 0.97
Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxicol (2000) 0.97
Central nervous system toxicity of manganese. I. Inhibition of spontaneous motor activity in rats after intrathecal administration of manganese chloride. Fundam Appl Toxicol (1995) 0.96
Structural basis of the antagonism between inorganic mercury and selenium in mammals. Chem Res Toxicol (2000) 0.96
Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol Appl Pharmacol (1999) 0.95
The deoxycytidylate deaminase found in Bacillus subtilis infected with phage SP8. Biochemistry (1967) 0.95
Central nervous system toxicity of manganese. II: Cocaine or reserpine inhibit manganese concentration in the rat brain. Neurotoxicology (1999) 0.95
Polyoma pseudovirions. I. Sequence of events in primary mouse embryo cells leading to pseudovirus production. J Virol (1972) 0.93
Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol Appl Pharmacol (1999) 0.92
Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat. J Pharmacol Exp Ther (1993) 0.91
Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology (1994) 0.91
Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation. J Pharmacol Exp Ther (1990) 0.91
Behavioral effects of low-level exposure to Hg0 among dental professionals: a cross-study evaluation of psychomotor effects. Neurotoxicol Teratol (1998) 0.89
Fluorometric determination of 2,3-dimercaptopropane-1-sulfonic acid and other dithiols by precolumn derivatization with bromobimane and column liquid chromatography. J Chromatogr (1986) 0.88
Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid. Toxicol Appl Pharmacol (1989) 0.87
DMSA, DMPS, and DMPA--as arsenic antidotes. Fundam Appl Toxicol (1984) 0.87
Cell-free assembly of a polyoma-like particle from empty capsids and DNA. Virology (1979) 0.86
Protection of mice against the lethal effects of sodium arsenite by 2,3 dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid. Biochem Biophys Res Commun (1980) 0.86
Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem Res Toxicol (2000) 0.86
Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein. Fundam Appl Toxicol (1990) 0.85
Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides. J Pharmacol Exp Ther (1996) 0.85
Diversity of inorganic arsenite biotransformation. Biol Trace Elem Res (1999) 0.83
Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro. Toxicol Appl Pharmacol (1998) 0.83
Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutat Res (1997) 0.83
DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther (1998) 0.83
Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. J Pharmacol Exp Ther (1996) 0.83
The use of DNA for gene therapy--the need, experimental approach, and implications. Perspect Biol Med (1970) 0.83
Polyoma pseudovirions. II. Influence of host cell on pseudovirus production. J Virol (1973) 0.83
Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine. Anal Biochem (1987) 0.82
Protection of mice against lethal effects of sodium arsenite--a quantitative comparison of a number of chelating agents. Toxicol Appl Pharmacol (1981) 0.81
Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine. Toxicol Appl Pharmacol (1989) 0.81
Polyoma-like particle: characterization of the DNA encapsidated in vitro by polyoma empty capsids. J Biol Chem (1982) 0.81
Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acid. Adv Enzyme Regul (1982) 0.81
Evaluation of Drosophila melanogaster as an alternative animal for studying the neurotoxicity of heavy metals. Biometals (1992) 0.80
The synthesis and breakdown of nucleic acids in mammalian cells transformed by oncogenic viruses. I. Purification and properties of an endonuclease from baby hamster kidney cells transformed by polyoma virus. J Biol Chem (1970) 0.80
The polyoma pseudovirion--its properties, production, and use in transferring DNA to mouse and human cells. Johns Hopkins Med J Suppl (1973) 0.79
Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rat. Toxicology (1996) 0.79
Sequential cleavage of dinucleotides from DNA by phage Sp3 DNAse. Proc Natl Acad Sci U S A (1968) 0.79
BAL increases the arsenic-74 content of rabbit brain. Toxicol Appl Pharmacol (1983) 0.78
Degradation of pseudoviral DNA after infection of mouse cells with polyoma pseudovirions. Proc Natl Acad Sci U S A (1974) 0.78
Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid. Life Sci (1982) 0.78
Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid. Biochem Pharmacol (1989) 0.77
Utilization of renal slices to evaluate the efficacy of chelating agents for removing mercury from the kidney. Toxicology (1997) 0.77
N-(2,3-dimercaptopropyl)phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication. Toxicol Appl Pharmacol (1984) 0.77
Synthesis and properties of the monomethyl ester of meso-dimercaptosuccinic acid and its chelates of lead (II), cadmium(II), and mercury(II). Chem Res Toxicol (1991) 0.76
Lead chelates of meso- and racemic-dimercaptosuccinic acid. J Inorg Biochem (1989) 0.76
Gene therapy systems: the need, experimental approach, and implications. Ann N Y Acad Sci (1971) 0.76
Penicillamine and analogous chelating agents. Ann N Y Acad Sci (1971) 0.76
Experimental gene delivery systems for mammalian cells-the polyoma pseudovirus system. Adv Enzyme Regul (1978) 0.75
Sequential cleavage of dinucleotides from DNA by SP3 DNase. 3. Substrate specificity and initiation of the hydrolysis from the 5-terminus of polynucleotides. J Mol Biol (1970) 0.75
Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite. J Pharmacol Exp Ther (1983) 0.75
[Science requires]. Vie Med Can Fr (1972) 0.75
Gene transfer by polyoma-like particles assembled in a cell-free system. Science (1983) 0.75
Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit. Drug Metab Dispos (1988) 0.75
Polyoma pseudovirions: an experimental model for the development of DNA for gene therapy. Fed Proc (1972) 0.75
Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit. Toxicol Appl Pharmacol (1985) 0.75
DL- and meso-dimercaptosuccinic acid: in vitro and in vivo studies with sodium arsenite. Toxicol Appl Pharmacol (1983) 0.75
Water soluble dithiol metal binding agents--efficacies and biotransformation. Acta Pharmacol Toxicol (Copenh) (1986) 0.75
Assembly of a polyoma-like particle from empty capsids and DNA in a cell-free system. Adv Enzyme Regul (1980) 0.75
The dimethyl ester of meso-2,3-dimercaptosuccinic acid and its interactions with Cd2+ and rabbit liver metallothionein I. Chem Res Toxicol (1992) 0.75